Literature DB >> 9204411

Drug elimination in chronic liver diseases.

P M Huet1, J P Villeneuve, D Fenyves.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9204411     DOI： 10.1016/s0168-8278(97)80498-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

1.  Medical Care of the Patient With Compensated Cirrhosis.

Authors:  Jorge L Herrera; Reynaldo Rodríguez
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-02

2.  Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate.

Authors:  Paul Snell; Nisha Dave; Katie Wilson; Lucy Rowell; Angelica Weil; Lawrence Galitz; Richard Robson
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

3.  Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time 13C-methacetin breath test.

Authors:  Michael Haimerl; Irene Fuhrmann; Stefanie Poelsterl; Claudia Fellner; Marcel D Nickel; Kilian Weigand; Marc H Dahlke; Niklas Verloh; Christian Stroszczynski; Philipp Wiggermann
Journal:  Eur Radiol       Date:  2018-03-12       Impact factor: 5.315

Review 4.  Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.

Authors:  Catherine C Crone; Geoffrey M Gabriel
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 5.  Pharmacokinetic drug interactions in liver disease: An update.

Authors:  Pietro Palatini; Sara De Martin
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

6.  An evaluation of hepatotoxicity in breast cancer patients receiving injection Doxorubicin.

Authors:  G Damodar; T Smitha; S Gopinath; S Vijayakumar; Ya Rao
Journal:  Ann Med Health Sci Res       Date:  2014-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.